Roxadustat treatment for erythropoiesis-stimulating agent-hyporesponsive anemia in maintenance hemodialysis patients

Objective Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) is a prevalent problem affecting hemodialysis (HD) patients. Roxadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor that stimulates erythropoiesis and regulates iron metabolism. We explored the ability of r...

Cijeli opis

Bibliografski detalji

Glavni autori:	Jie Song, Xiaojun Chen, Linshan Zhou, Weihong Yu, Hong Liu, Fang Yuan
Format:	Artigo
Jezik:	Inglês
Izdano:	SAGE Publishing 2023-10-01
Serija:	Journal of International Medical Research
Online pristup:	https://doi.org/10.1177/03000605231204475
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!